Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,914 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment.
Miki T, Nakatsuka K, Naka H, Masaki H, Imanishi Y, Ito M, Inaba M, Morii H, Nishizawa Y. Miki T, et al. J Bone Miner Metab. 2004;22(6):569-76. doi: 10.1007/s00774-004-0525-z. J Bone Miner Metab. 2004. PMID: 15490267 Clinical Trial.
Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004).
Nishizawa Y, Nakamura T, Ohta H, Kushida K, Gorai I, Shiraki M, Fukunaga M, Hosoi T, Miki T, Chaki O, Ichimura S, Nakatsuka K, Miura M; Committee on the Guidelines for the Use of Biochemical Markers of Bone Turnover in Osteoporosis Japan Osteoporosis Society. Nishizawa Y, et al. Among authors: miki t. J Bone Miner Metab. 2005;23(2):97-104. doi: 10.1007/s00774-004-0547-6. J Bone Miner Metab. 2005. PMID: 15750686 No abstract available.
Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition).
Nishizawa Y, Miura M, Ichimura S, Inaba M, Imanishi Y, Shiraki M, Takada J, Chaki O, Hagino H, Fukunaga M, Fujiwara S, Miki T, Yoshimura N, Ohta H; from the Japan Osteoporosis Society Bone Turnover Marker Investigation Committee. Nishizawa Y, et al. Among authors: miki t. Clin Chim Acta. 2019 Nov;498:101-107. doi: 10.1016/j.cca.2019.08.012. Epub 2019 Aug 16. Clin Chim Acta. 2019. PMID: 31425674 Free article. Review.
Risk factors for osteoporosis in men.
Izumotani K, Hagiwara S, Izumotani T, Miki T, Morii H, Nishizawa Y. Izumotani K, et al. Among authors: miki t. J Bone Miner Metab. 2003;21(2):86-90. doi: 10.1007/s007740300014. J Bone Miner Metab. 2003. PMID: 12601572
Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy.
Kitatani K, Nakatsuka K, Naka H, Miki T, Morii H, Nishizawa Y. Kitatani K, et al. Among authors: miki t. J Bone Miner Metab. 2003;21(4):217-24. doi: 10.1007/s00774-003-0412-z. J Bone Miner Metab. 2003. PMID: 12811626 Clinical Trial.
Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).
Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fujiwara S, Miki T, Sagawa A, Nishizawa Y, Seino Y; Subcommittee to Study Diagnostic Criteria for Glucocorticoid-Induced Osteoporosis. Nawata H, et al. Among authors: miki t. J Bone Miner Metab. 2005;23(2):105-9. doi: 10.1007/s00774-004-0596-x. J Bone Miner Metab. 2005. PMID: 15750687 No abstract available.
A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial.
Matsumoto T, Miki T, Hagino H, Sugimoto T, Okamoto S, Hirota T, Tanigawara Y, Hayashi Y, Fukunaga M, Shiraki M, Nakamura T. Matsumoto T, et al. Among authors: miki t. J Clin Endocrinol Metab. 2005 Sep;90(9):5031-6. doi: 10.1210/jc.2004-2552. Epub 2005 Jun 21. J Clin Endocrinol Metab. 2005. PMID: 15972580 Clinical Trial.
2,914 results